Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

3d printing and biofabrication


Published on

Presentation at the UMCU Summerschool for Biofabrication and 3d printing about legal and regulatory aspects

  • Dating for everyone is here: ♥♥♥ ♥♥♥
    Are you sure you want to  Yes  No
    Your message goes here
  • Dating direct: ❶❶❶ ❶❶❶
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

3d printing and biofabrication

  1. 1. REGULATORY AND LEGAL ASPECTS OF 3D PRINTING Utrecht Summer School Course: Biofabrication 16 July 2014 Erik Vollebregt
  2. 2. Agenda • How does the law see 3D printing? • Regulation of various aspects of 3D printing • Intellectual property • Personal data
  3. 3. How the law sees 3d printing You use a production facility • Medical devices and medicial products production facilities are regulated (GMP, ISO 13485) You make something that can be regulated • Medical device, advanced therapy medicinal product You use materials that can be regulated • Parts for devices and substances for medicinal products are regulated; harvest, transport and use of biologic material is regulated You apply a process that can be regulated • Manufacturing processes for medicinal products and devices require a quality system
  4. 4. How the law sees 3d printing You use data that pertain to an identified or identifiable person • Collection and processing of personal data concerning health • Customisation links objects to persons • Data can be breached, stolen etc
  5. 5. Regulation of the printer Currently: EU Machinery Directive
  6. 6. Regulation of the material • REACH (chemical substances) • EU Tissues & Cells Directive (cells and tissues)
  7. 7. Regulation of the end result • Can be a medical device • Can be an advanced therapy medicinal product
  8. 8. Regulation of the end result Medical devices law • Currently custom-made device • Prescription defines end result but production technique is standardised • Question: what is “custom” about a 3D printed medical device? ATMP regulation • Tissue engineered product • May contain additional substances or objects, like scaffolds • ATMP unless completely unviable • Cells / tissues substantially manipulated • Combined advanced therapy medicinal products
  9. 9. Regulation of the end result The new Proposal on Medical Device Regulation increases standards for non custom-made 3D printed medical devices by introducing stricter identification (UDI), traceability and registration requirements.
  10. 10. Regulation of the activity • Quality system requirements / GMP requirements
  11. 11. Intellectual property: general • Copyright • Software • Software model for device / bodypart • Patents • Printing method (e.g. living cells) • End result (ear with particular properties) • Printing materials • Contributory Patent infringement: - the individual operating the 3D printer, and - the designer of the CAD file/s.
  12. 12. Intellectual property: body parts
  13. 13. Personal data 3d printing related activities involve collection and processing of personal data concerning health on many levels • Data from hospital’s electronic health records • Generation of patient related data for end product • Data in files describing the end product • Etc. Who controls the data? • Controller has regulatory burden, must conclude processing agreement with others that get access to the data Where is the data? • External printing lab? • Hosted? • Sent outside of EU for e.g. modelling?
  14. 14. THANKS FOR YOUR ATTENTION Erik Vollebregt Axon Lawyers Piet Heinkade 183 1019 HC Amsterdam T +31 88 650 6500 F +31 88 650 6555 M +31 6 47 180 683 E @meddevlegal B READ MY BLOG: